Uncategorized

Cash infusion to provide company with additional resources for accelerated growth PALM BEACH GARDENS, Fla., JANUARY 18, 2024 (GLOBE NEWSWIRE) –  Accelus, a privately held medical technology company committed to becoming the global market leader in expandable spinal implant technologies, announced today that it has received a significant financial investment through a $20 million debt …

Accelus Announces Closing of $20 Million Debt Facility with Symbiotic Capital Read More »

PALM BEACH GARDENS, Fla., December 7, 2023 (GLOBE NEWSWIRE) – Accelus, a privately held medical technology company committed to becoming the global market leader in expandable spinal implant technologies, today announced its latest strategic initiative: bolstering awareness and adoption of its proprietary Adaptive Geometry™ technology, showcased in its flagship FlareHawk® Interbody Fusion System, to meet …

Accelus Announces Renewed Focus on Pioneering Minimally Invasive Outpatient Procedures with Its Advanced Adaptive Geometry Technology Read More »

PALM BEACH GARDENS, Fla., April 19, 2023 (GLOBE NEWSWIRE) — Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the standard of care in spine, has announced a leadership change and reorganization, as well as the sale of its Remi® Robotic Navigation System assets to Alphatec Holdings, Inc. (Nasdaq: ATEC). …

Accelus Sells Remi Robotic Navigation System to Alphatec and Announces Leadership Change to Drive Growth and Innovation Read More »

Remi now cleared for use with most commonly used 2D and 3D imaging systems for spine surgery PALM BEACH GARDENS, Fla., March 16, 2023 (GLOBE NEWSWIRE) – Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the standard of care in spine, today announced that the …

Accelus Announces FDA 510(k) Clearance of Remi Robotic Navigation System for Use with 2D Fluoroscopy-Based Imaging System Read More »

PALM BEACH GARDENS, Fla., November 3, 2022 (GLOBE NEWSWIRE) – Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the standard of care in spine, today announced that the U.S. Food & Drug Administration (FDA) had cleared Accelus’s 510(k) application for its Remi™ Robotic Navigation System …

Accelus Announces FDA 510(k) Clearance for Remi Robotic Navigation System Software Update that Allows Image Acquisition with all Major 3D Imaging Systems Read More »

Surgeons in 19 Countries Can Now Take Advantage of FlareHawk’s Minimal Insertion Profile, Multiplanar and Endplate-Conforming Expansion, and Maximum Graft Delivery PALM BEACH GARDENS, Fla., October 18, 2022 – Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the standard of care in spine, today announced …

Accelus Announces Global Expansion of its FlareHawk Interbody Fusion System Read More »

PALM BEACH GARDENS, Fla., October 10, 2022 – Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the standard of care in spine, today announced that more than 15,000 FlareHawk® multiplanar expandable cages have been implanted in more than 11,000 patients in the United States. “FlareHawk …

Accelus Announces New Milestone with Its FlareHawk® Interbody Fusion System Surpassing 15,000 Devices Implanted Read More »

New expandable interbody enables up to a 34mm-wide footprint from a posterior approach with up to 2cm2 of bone graft contact area through the implant PALM BEACH GARDENS, Fla., August 15, 2022 – Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the standard of care …

Accelus Announces First Surgeries Using FlareHawk® TiHawk11™ Interbody Fusion System Read More »

PALM BEACH GARDENS, Fla., July 14, 2022 (GLOBE NEWSWIRE) – Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the standard of care in spine, today announced Vail-Summit Orthopaedics and Neurosurgery (VSON) as the first ambulatory surgery center (ASC) to acquire the Remi Robotic Navigation System, …

Accelus Announces Vail-Summit Orthopaedics and Neurosurgery as First Ambulatory Surgery Center to Adopt Remi™ Robotic Navigation System Read More »

CHP Co-Founder and Partner Joseph Swedish Named to Accelus Board of Directors PALM BEACH GARDENS, Fla., July 12, 2022 (GLOBE NEWSWIRE) – Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the standard of care in spine, today announced the closing of a $12 million lead …

Accelus Announces Series D Equity Financing Led by Concord Health Partners (CHP) Read More »